Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1980 1
1981 1
1983 1
1984 2
1985 4
1986 4
1987 7
1988 6
1989 6
1990 7
1991 3
1992 2
1993 2
1994 4
1995 2
1996 8
1997 7
1998 1
1999 2
2000 5
2001 3
2002 5
2003 1
2004 6
2005 4
2006 12
2007 11
2008 10
2009 5
2010 14
2011 15
2012 12
2013 10
2014 13
2015 8
2016 4
2017 5
2018 5
2019 4
2020 2
2021 2
2023 4
2024 2
2025 1
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models.
Jesudason CD, Rangel-Barajas C, Beach CJ, Beck DE, Caballero-Floran IH, Clayton WB, Da Silva L, David JC, Doolen S, Faulkner AN, Hamdani AK, Huhe H, Huynh K, Imhoff RD, Javens-Wolfe J, Mason ER, Moussaif M, Singhal K, Soni DM, van Buuren-Milne M, Williams SP, Angus SP, Chu S, Dage JL, Hipskind PA, Johnson TS, Kaddurah-Daouk R, Lamb BT, Meikle PJ, Mesecar AD, Palkowitz AD, Quinney SK, Sukoff Rizzo SJ, Oblak AL, Richardson TI. Jesudason CD, et al. Among authors: beck de. bioRxiv [Preprint]. 2026 Jan 2:2025.12.31.697127. doi: 10.64898/2025.12.31.697127. bioRxiv. 2026. PMID: 41509252 Free PMC article. Preprint.
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's disease.
Jesudason CD, Mason ER, Chu S, Oblak AL, Javens-Wolfe J, Moussaif M, Durst G, Hipskind P, Beck DE, Dong J, Amarasinghe O, Zhang ZY, Hamdani AK, Singhal K, Mesecar AD, Souza S, Jacobson M, Salvo JD, Soni DM, Kandasamy M, Masters AR, Quinney SK, Doolen S, Huhe H, Rizzo SJS, Lamb BT, Palkowitz AD, Richardson TI. Jesudason CD, et al. Among authors: beck de. Alzheimers Dement (N Y). 2023 Nov 17;9(4):e12429. doi: 10.1002/trc2.12429. eCollection 2023 Oct-Dec. Alzheimers Dement (N Y). 2023. PMID: 38023622 Free PMC article.
A novel fluorogenic reporter substrate for 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (PLCγ2): Application to high-throughput screening for activators to treat Alzheimer's disease.
Visvanathan R, Utsuki T, Beck DE, Lendy E, Sun KL, Liu Y, Hering KW, Mesecar A, Zhang ZY, Putt KS. Visvanathan R, et al. Among authors: beck de. SLAS Discov. 2023 Jun;28(4):170-179. doi: 10.1016/j.slasd.2023.03.003. Epub 2023 Mar 17. SLAS Discov. 2023. PMID: 36933698 Free PMC article.
Endoscopic Management of Bowel Obstruction.
Beck DE. Beck DE. Clin Colon Rectal Surg. 2021 Jul;34(4):262-268. doi: 10.1055/s-0041-1725947. Epub 2021 Apr 15. Clin Colon Rectal Surg. 2021. PMID: 34305475 Free PMC article. Review.
232 results